PCT Application

A PCT application (formally, an "international application" under the Patent Cooperation Treaty) is a single patent filing, administered by WIPO, that preserves an applicant's right to seek patent protection in some or all of the PCT's 158 Contracting States without having to file separately in each one at the outset. It does not itself result in a granted patent anywhere -- grant authority stays with each national or regional patent office. For a university invention, something qualifies operationally as a PCT application if it is filed with a receiving office (typically the USPTO, for a US-origin invention) within 12 months of the earliest priority filing (usually a US provisional application), enters an international phase producing a search report and written opinion on patentability, and is then converted into individual national or regional applications -- "national phase entry" -- by the applicable deadline (30 months from priority under the PCT default, though several major offices set 31 months). A TTO's PCT decision is fundamentally a triage decision: it buys roughly 18 extra months, beyond the original 12-month priority year, to assess commercial interest (licensee engagement, industry validation, additional data) before committing to the far higher cost of national-phase filing in specific countries.

ByCASRAI Editorial Board

· Last updated 23 Jul 2026

Worked examples

Is an instance

A university spinout files a US provisional application disclosing a new diagnostic assay. Eleven months later, with a licensee showing serious interest but no signed deal yet, the TTO files a PCT application claiming priority to the provisional. This converts one filing into a placeholder for patent rights across all 158 PCT Contracting States and buys roughly 18 more months -- until the 30-month national-phase deadline -- to negotiate a license before deciding which specific countries (the US, likely the EPO, possibly Japan) are worth the national-phase cost.

Is an instance

A materials-science lab's invention has thin commercial signal at the 12-month priority deadline -- no licensee conversations, unclear market. Rather than let the priority right lapse, the TTO files a PCT application specifically to preserve optionality cheaply (PCT international-phase fees are a fraction of filing in even three or four countries directly) while it keeps shopping the technology; if nothing materializes by the national-phase deadline, it simply lets the PCT application lapse with no country-level cost sunk.

Looks similar, but isn't

Not an instance

A TTO decides at month 10 that an invention should be protected only in the United States, with no realistic international licensing market. Filing a nonprovisional US utility application directly (claiming priority to the provisional) is the correct move here, not a PCT application -- the PCT route adds WIPO international-phase fees and administrative overhead for countries the institution was never going to pursue, with no offsetting benefit when the territorial scope is already known and US-only.

A PCT application — an international application filed under the Patent Cooperation Treaty, administered by the World Intellectual Property Organization (WIPO) — is the mechanism a technology transfer office (TTO) uses to preserve patent rights across multiple countries with a single filing, while deferring the country-by-country decision and its much larger cost. It is not a global patent: no such thing exists. A PCT application never itself results in a granted patent anywhere; it is a placeholder that must eventually convert into real national or regional applications, examined and granted (or refused) independently by each office.

Why a TTO files a PCT application instead of going straight to national filings

For a university invention, the practical driver is timing risk. A first patent filing — typically a US provisional application — starts a strict 12-month Paris Convention priority window. By that deadline, a TTO must decide where, if anywhere, to pursue protection abroad. At month 12, licensing interest is frequently still unresolved: a company may be interested but not yet under a term sheet, or the invention may still be seeking its first industry conversation. Filing a PCT application at that point does two things a national filing can’t: it holds the applicant’s place in all 158 PCT Contracting States at once, and it pushes the true country-selection decision out to the national-phase deadline — 30 months from the priority date under the PCT’s default rule, though several major offices (the EPO, KIPO, IP Australia, and India’s patent office among them) extend this to 31 months, and a small number of jurisdictions set shorter deadlines. That extra roughly-18-month runway is the entire commercial value of the PCT route for a TTO: more time to secure a licensee, gather validation data, or confirm market interest before spending real money on individual country filings.

What happens during the PCT’s international phase

Once filed with a receiving office (for a US-origin invention, ordinarily the USPTO), the application enters an international phase. An International Searching Authority (ISA) — for US filers, usually the USPTO or the European Patent Office — produces an international search report and a non-binding written opinion on patentability. International publication follows at 18 months from the priority date. Applicants can optionally request Chapter II examination (a formal “demand” for international preliminary examination under PCT Article 31), which produces an International Preliminary Report on Patentability from an International Preliminary Examining Authority. None of this is a grant decision — it is diligence the TTO and its licensees can use to gauge patentability strength before committing to national-phase costs, and prospective licensees often treat a favorable written opinion as real signal during negotiations.

National phase entry: where the real cost commitment happens

The PCT application’s life ends at the national-phase deadline. By then, the applicant must affirmatively enter national or regional phase — filing translated applications, paying national fees, and typically engaging local patent counsel — in each specific country or region (such as the European Patent Office, for the EPO’s own regional route) where protection is still wanted. This is where PCT costs stop being modest: national-phase entry in even three or four jurisdictions multiplies translation, attorney, and official fees well beyond the PCT’s own transmittal, search, and international filing fees. A TTO that let a PCT application lapse without picking any countries has spent the international-phase fees but avoided the much larger national-phase commitment — which is exactly the risk-deferral trade the PCT route is built around.

Related CASRAI content

PCT Patent Application: The International Filing Route Explained — a full walkthrough of the filing mechanics, fees, and timeline.
IP Docketing — how TTOs track the 12-month priority and 30/31-month national-phase deadlines a PCT application creates across a portfolio.
Provisional Patent Applications — the usual first filing that starts the priority clock a PCT application later extends.
Utility Patent — what a PCT application eventually converts into at national phase.
Cost of Filing a Patent — USPTO, attorney, and PCT/WIPO fee detail.
Invention Disclosure — the upstream step that starts the priority-filing clock a PCT application is timed against.
Tech Transfer cluster overview.

Use in your systems

JATS XML <role> element

xml

<role vocab="credit"
      vocab-identifier="https://casrai.org/dictionary/"
      vocab-term="PCT Application"
      vocab-term-identifier="https://casrai.org/dictionary/term/pct-application" />

Schema.org DefinedTerm (JSON-LD)

json

{
  "@context": "https://schema.org",
  "@type": "DefinedTerm",
  "@id": "https://casrai.org/dictionary/term/pct-application",
  "name": "PCT Application",
  "identifier": "https://casrai.org/dictionary/term/pct-application",
  "description": "A PCT application (formally, an \"international application\" under the Patent Cooperation Treaty) is a single patent filing, administered by WIPO, that preserves an applicant's right to seek patent protection in some or all of the PCT's 158 Contracting States without having to file separately in each one at the outset. It does not itself result in a granted patent anywhere -- grant authority stays with each national or regional patent office. For a university invention, something qualifies operationally as a PCT application if it is filed with a receiving office (typically the USPTO, for a US-origin invention) within 12 months of the earliest priority filing (usually a US provisional application), enters an international phase producing a search report and written opinion on patentability, and is then converted into individual national or regional applications -- \"national phase entry\" -- by the applicable deadline (30 months from priority under the PCT default, though several major offices set 31 months). A TTO's PCT decision is fundamentally a triage decision: it buys roughly 18 extra months, beyond the original 12-month priority year, to assess commercial interest (licensee engagement, industry validation, additional data) before committing to the far higher cost of national-phase filing in specific countries.",
  "inDefinedTermSet": "https://casrai.org/dictionary/domain/tech-transfer#set",
  "url": "https://casrai.org/dictionary/term/pct-application",
  "sameAs": [],
  "license": "https://creativecommons.org/licenses/by/4.0/",
  "publisher": {
    "@id": "https://casrai.org/#organization"
  },
  "dateModified": "2026-07-23T03:51:29",
  "inLanguage": "en"
}